E
Standard BioTools Inc. LAB
$1.06 $0.06616.65% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -47.56% -86.03% -64.53% -40.99% 31.14%
Total Depreciation and Amortization -3.17% 31.21% 64.31% 597.70% 481.06%
Total Amortization of Deferred Charges -9.14% -- -201.80% -152.94% -123.37%
Total Other Non-Cash Items 3,338.62% -57.23% -74.73% -83.36% -98.41%
Change in Net Operating Assets 10.22% -1,380.58% -897.69% -161.93% -36.51%
Cash from Operations -14.37% -231.40% -196.35% -106.15% -18.25%
Capital Expenditure -385.32% -195.13% -43.99% 4.29% 34.41%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -100.49% -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 315.96% 302.64% -36.00% -79.04% 144.17%
Cash from Investing -79.77% 1,694.60% 340.67% 127.38% 769.22%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -435.28% -2,933.70% -1,033.49% -- --
Issuance of Common Stock 122.25% 150.30% 169.68% 165.15% -2.81%
Repurchase of Common Stock -112.81% -637.42% -587.84% -631.40% -332.31%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- -- 95.66%
Cash from Financing -245.77% -1,407.06% -708.08% -922.19% -111.41%
Foreign Exchange rate Adjustments -3,970.00% -2,408.82% -342.02% -68.75% 96.62%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -177.56% 490.01% 583.59% 89.01% 108.35%